Article
Host-directed therapy in diabetes and tuberculosis comorbidity toward global tuberculosis elimination
9 Mar 2025
Abstract excerpt
Host-directed therapy could potentially revolutionize tuberculosis control as an adjunct to traditional antibiotics for the treatment of tuberculosis disease and as a strategy to prevent disease progression following Mycobacterium tuberculosis infection. The growing type 2 diabetes pandemic is hampering tuberculosis control worldwide, as people with diabetes have an increased risk of developing tuberculosis...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
